Mosaic Family Wealth’s Alexion Pharmaceuticals ALXN Stock Holding History

Mosaic Family Wealth’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-263	Closed	-$36K	–	661
2019 Q1	$36K	Hold	263	–	–	0.01%	353
2018 Q4	$26K	Hold	263	–	–	0.01%	394
2018 Q3	$31K	Hold	263	–	–	0.01%	377
2018 Q2	$33K	Hold	263	–	–	0.01%	366
2018 Q1	$29K	Hold	263	–	–	0.01%	380
2017 Q4	$31K	Sell	263 -15	-5%	-$1.83K	0.01%	393
2017 Q3	$39K	Buy	278 +15	+6%	+$2.04K	0.02%	373
2017 Q2	$32K	Hold	263	–	–	0.01%	382
2017 Q1	$32K	Hold	263	–	–	0.01%	386
2016 Q4	$32K	Hold	263	–	–	0.01%	373
2016 Q3	$32K	Hold	263	–	–	0.01%	386
2016 Q2	$31K	Hold	263	–	–	0.02%	390
2016 Q1	$36K	Hold	263	–	–	0.02%	362
2015 Q4	$50K	Buy	+263	New	+$45.9K	0.02%	327

Other funds holding ALXN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Mosaic Family Wealth's ALXN Position: Q2 2019 in Review

Mosaic Family Wealth sold out of Alexion Pharmaceuticals (ALXN) in Q2 2019, closing a stake of 263 shares — an estimated $36K sold.

Mosaic Family Wealth first reported a position in ALXN in Q4 2015 and held it in 14 quarters. The position peaked at $50K in Q4 2015. 636 funds tracked by Wall St. Rank hold ALXN as of Q2 2019.

Mosaic Family Wealth reported no remaining Alexion Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Mosaic Family Wealth sold 263 Alexion Pharmaceuticals shares in Q2 2019, an estimated $36K.
Mosaic Family Wealth first reported a position in Alexion Pharmaceuticals in Q4 2015 and held it in 14 quarters.
Mosaic Family Wealth's Alexion Pharmaceuticals position peaked at $50K in Q4 2015.
636 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2019.

Based on Mosaic Family Wealth's 13F filing for Q2 2019, filed 12 Aug 2019.